<DOC>
	<DOCNO>NCT01914536</DOCNO>
	<brief_summary>This project observational prospective study patient affect adult onset Pompe disease followed-up three year use different clinical , analytical radiological test order know natural history disease impact treatment recombinant enzyme progression disease .</brief_summary>
	<brief_title>A Natural History Study Adult Onset Pompe Disease Using Muscle MRI</brief_title>
	<detailed_description>Study aim : The principal objective study find biomarkers quantify natural progression disease know useful determine improvement lack impairment disease response Enzyme Replacement Therapy ( ERT ) . Study design : A single center observational prospective study . Patients : Patients adult onset POMPE disease ( onset symptom two year old ) molecular diagnosis confirm disease eligible Methods : Clinical information obtain accord pre-defined protocol include six visit : screen visit , baseline , 6 month , 12 month , 24 month 36 month . In visit perform follow test : clinical assessment ( include interview patient , quality live questionnaire , time test assessment muscle balance use myometer ) , analytical test ( blood urine test ) , cardiac test ( Electrocardiogram ( ECG ) cardiac echography ) , respiratory assessment ( use spirometer ) skeletal muscle imaging ( Muscle MRI ) . All data collect introduce database afterwards statistically analyze . Expected result : We expect find biomarker useful follow-up progression Pompe disease . This biomarker sensitive change muscle function may treatment ERT . Funding : This project fund Genzyme , Sanofi company</detailed_description>
	<mesh_term>Glycogen Storage Disease Type II</mesh_term>
	<criteria>Pompe disease confirm use genetic study Onset symptoms 2 year old To able come hospital follow visit Patients respiratory involvement welcome Patients unable perform MRI ( respiratory problem solve use mechanical ventilation )</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>POMPE</keyword>
	<keyword>Glycogenosis type II</keyword>
	<keyword>Acid maltase deficiency</keyword>
</DOC>